Upper limb function
Background.-Studies have demonstrated reduction of spastic dystonia with sustained stretch. The aim of the present work was to evaluate the effects of upper limb wrist-worn loading in a patient with elbow flexor spastic dystonia.
Methods.-A 53-year old male with left spastic hemiparesis secondary to a cerebral infarct 2 years prior has benefited from a 3-month rehabilitation program, including botulinum toxin injections at the Neurorehabilitation Day Hospital in Albert-Chenevier hospital, Créteil, France. Within this program the patient has worn a loaded wrist splint (1.5 kg) daily. Every day, he reported the total loading time together with any untoward effects in a diary. Once monthly we monitored spasticity with the Tardieu Scale and active arm function with the Modified Frenchay Scale using blinded review by two examiners. Keywords: Stroke; Paraspinal; Botulinum; Toxin Background.-Type A botulinum toxin has been used in paraspinal muscles for several conditions like stiff-person syndrome, back pain in cerebral palsy, chronic low back pain, X-linked dystonia-parkinsonism. Methods.-A 30-years old woman developed a spastic quadriplegia with right side more involved, after a severe stroke at the age of 19. Although she was following a rehabilitation programme for several years, she only improved her ability to walk slowly for up to 30 steps unaided.
Results.-After treatment with type A botulinum toxin (Botox) for 6 years in limb muscles, during the last 2 years, she developed a scoliosis which interfered with her gait pattern. Right paraspinal thoracic muscles were injected, with botulinum toxin in 6 segments, using 20 U in each site. This treatment was repeated 4 times each year. Patient improved posture in standing position and facilitated the gait pattern and velocity. She could walk more than 50 steps without assistance, without body shifting and with a faster gait speed. Keywords: Cervical dystonia; Spasmodic torticollis; Botulinum toxin; IncobotulinumtoxinA Background.-Current prescribing information recommends botulinum toxin (BoNT) treatment intervals for cervical dystonia (CD) ≥ 12 weeks (≥ 10 weeks for incobotulinumtoxinA European labelling). However, many patients experience recurrence of symptoms before 12 weeks have elapsed.
Methods.-A cross-sectional survey of patients with CD collected data on BoNT treatment intervals received and preferred intervals [1] . These were compared with intervals from an incobotulinumtoxinA clinical study in CD where patients were re-injected at flexible intervals ≥ 6 weeks based on patients' requests and investigator-confirmed clinical need for retreatment [2] .
Results.-Most (78.4%) patients in the survey (n = 136) preferred treatment intervals ≤ 12 weeks; 46.3% preferred intervals ≤ 10 weeks. However, 47.1% of survey patients received intervals ≤ 12 weeks; 4.4% received intervals ≤ 10 weeks. In the clinical study, 821 incobotulinumtoxinA treatments were given at intervals of 6-20 weeks; 44.9% of treatments were given at intervals.
Conclusions.-Many patients with CD would like individualised BoNT treatment regimens. When flexible treatment intervals are permitted, many patients choose shorter or longer intervals than the 12-week standard-of-care interval.
